Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron K Aragaki

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Menopause (New York, N.Y.)|February 22, 2024
Letter to the EditorRowan T Chlebowski, Aaron K Aragaki
JAMA|March 21, 2023
Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal PersonsRowan T Chlebowski, Aaron K Aragaki
Lifetime Data Analysis|April 27, 2026
The semi-competing risk problem revisitedRoss L Prentice, Aaron K Aragaki
Menopause (New York, N.Y.)|February 2, 2023
The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in contextRowan T Chlebowski, Aaron K Aragaki
Breast Cancer Research and Treatment|September 20, 2023
Long-term breast cancer incidence trends by mammography, obesity, and menopausal hormone therapyRowan T Chlebowski, Aaron K Aragaki
JCO Oncology Practice|March 21, 2022
Breast Cancer Prevention and Breast Cancer MortalityRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
JCO Oncology Practice|July 28, 2021
Breast Cancer Prevention: Time for ChangeRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2013
Reply to S. Gandini et alRowan R Chlebowski, Aaron K Aragaki, Anne McTiernan
Journal of the National Cancer Institute|November 21, 2022
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort studyRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health InitiativeRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Menopause (New York, N.Y.)|February 22, 2024
Letter to the EditorRowan T Chlebowski, Aaron K Aragaki
JAMA|March 21, 2023
Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal PersonsRowan T Chlebowski, Aaron K Aragaki
Lifetime Data Analysis|April 27, 2026
The semi-competing risk problem revisitedRoss L Prentice, Aaron K Aragaki
Menopause (New York, N.Y.)|February 2, 2023
The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in contextRowan T Chlebowski, Aaron K Aragaki
Breast Cancer Research and Treatment|September 20, 2023
Long-term breast cancer incidence trends by mammography, obesity, and menopausal hormone therapyRowan T Chlebowski, Aaron K Aragaki
JCO Oncology Practice|March 21, 2022
Breast Cancer Prevention and Breast Cancer MortalityRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
JCO Oncology Practice|July 28, 2021
Breast Cancer Prevention: Time for ChangeRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2013
Reply to S. Gandini et alRowan R Chlebowski, Aaron K Aragaki, Anne McTiernan
Journal of the National Cancer Institute|November 21, 2022
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort studyRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health InitiativeRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson
Pageof 12